Viewbix Secures Shareholder Approval for Acquisition of Quantum X Labs

Viewbix received the requisite stockholder approval via written consent of the majority of its stockholders for its previously announced acquisition of Quantum X Labs. The acquisition, which was entered into pursuant to the definitive share purchase agreement dated December 15, 2025 involves Viewbix acquiring between 85% and 100% of Quantum's issued and outstanding share capital on a fully diluted basis. Quantum operates portfolio companies developing innovative solutions in quantum-based navigation, next-generation atomic clocks for precision timing, quantum algorithms for sectors such as transportation, drug discovery, biomedicine, and security, as well as advanced quantum error correction technologies. At closing, Viewbix will issue common stock and pre-funded warrants representing approximately 40% of its capital stock as of the Agreement Date, with potential additional consideration of up to 12,702,847 shares of the Company's common stock or pre-funded warrants upon achievement of specified post-closing milestones. With stockholder approval secured via written consent, the transaction remains subject to satisfaction of remaining closing conditions, including final due diligence and regulatory approvals. The Company expects the acquisition to close in the coming weeks.